{"transactions":[{"id":951927,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":70354,"kind":"person","name":"Wallace Eli M.","position":1,"cik":"0001776352","reported_name":"Wallace Eli M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T00:22:35.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":1114400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"69,650 of the shares underlying the option vested on January 2, 2026. Thereafter, 1/48th of the shares underlying the option will vest monthly, with full vesting scheduled for October 2, 2029, subject to the Reporting Person's continuous service with the Issuer on each such vesting date."}],"balance_after":1114400,"derivative":{"exercise_price":12.52,"expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":1114400},"source":{"system":"sec-edgar","filing":"0001193125-26-003027","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526003027/ownership.xml","form_type":"4"}},{"id":971394,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":70354,"kind":"person","name":"Wallace Eli M.","position":1,"cik":"0001776352","reported_name":"Wallace Eli M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-13T00:04:11.000Z","date":"2025-12-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1114400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 10, 2025, the Issuer rescinded 1,114,400 stock options that were part of the Reporting Person's option grant dated October 2, 2025 (the \"Rescinded Portion\"). The Rescinded Portion was cancelled and the remaining 500,000 stock options from the original grant continue to remain outstanding. The rescission was an exempt disposition to the Issuer per Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 2, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":500000,"derivative":{"exercise_price":12.44,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":1114400},"source":{"system":"sec-edgar","filing":"0001193125-25-317962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312525317962/ownership.xml","form_type":"4"}},{"id":1023443,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":70354,"kind":"person","name":"Wallace Eli M.","position":1,"cik":"0001776352","reported_name":"Wallace Eli M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-06T20:22:15.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":1614400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 2, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":1614400,"derivative":{"exercise_price":12.44,"expiration_date":"2035-10-01","underlying":"Common Stock","underlying_shares":1614400},"source":{"system":"sec-edgar","filing":"0001193125-25-231917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312525231917/ownership.xml","form_type":"4"}},{"id":1053712,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":70354,"kind":"person","name":"Wallace Eli M.","position":1,"cik":"0001776352","reported_name":"Wallace Eli M.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-28T20:36:16.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":499731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A fraction of the shares underlying such option equal to (x) the number of full months between August 11, 2025 (\"Vesting Commencement Date\") and the date on which a registration statement on Form S-8 is filed and effective with the Securities and Exchange Commission (the \"S-8 Filing Date\") divided by (y) 48 shall vest on the S-8 Filing Date, and 1/48th of the shares underlying such option shall vest each month thereafter on the day of the month corresponding to the Vesting Commencement Date (and if there is no suchcorresponding day for a month, then the vesting date shall be the last day of the applicable month) until 100% of the shares underlying such option is vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service the Issuer on each such vesting date."}],"balance_after":499731,"derivative":{"exercise_price":9.59,"expiration_date":"2035-08-25","underlying":"Common Stock","underlying_shares":499731},"source":{"system":"sec-edgar","filing":"0000950170-25-111992","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000095017025111992/ownership.xml","form_type":"4"}}]}